孟鲁司特钠联合三联雾化吸入治疗小儿喘息性支气管炎60例疗效分析

Analysis of 60 cases of children with asthmatic bronchitis treated by montelukast sodium combined with triple atomization inhalation

目的:临床观察孟鲁司特联合布地奈德、特布他林、异丙托溴胺雾化吸入治疗小儿喘息性支气管炎疗效分析。方法:选取60例喘息性支气管炎患儿,随机分为治疗组和对照组,两组性别、年龄、病程差异均无统计学意义(P>0.05),治疗组给予孟鲁司特联合布地奈德、特布他林、异丙托溴胺雾化吸入,对照组给予布地奈德、特布他林、异丙托溴胺雾化吸入,观察两组疗效情况。结果:经临床疗效分析,孟鲁司特联合布地奈德、特布他林、异丙托溴胺雾化吸入治疗在减轻咳嗽、喘息等症状及清除肺部喘鸣音等方面疗效显著,值得在临床推广应用。

Objective To observe the clinical efficacy of Montelukast Combined with budesonide,terbutaline and ipratropium bromide inhalation in the treatment of children with asthmatic bronchitis. Method 60 cases of children with asthmatic bronchitis were selected,they were randomly divided into treatment group and control group,There was no significant difference in gender,age and course of disease between the two groups（ P 〉 0. 05）,The treatment group was given Montelukast Combined with budesonide,terbutaline,ipratropium bromide inhalation,the control group was given budesonide,terbutaline,ipratropium bromide inhalation,the efficacy of the two groups were observed. Results The clinical curative effect analysis,meng Lu Si joint budesonide,terbutaline,isopropyl bromide amine atomization inhalation therapy in reducing symptoms such as coughing,wheezing and clearing lung wheezing curative effect is distinct,and is worth popularizing in clinical application.